دورية أكاديمية

Pharmacokinetics, safety, and tolerability of four 28-day cycle intramuscular injections for risperidone-ISM 75 mg in patients with schizophrenia: A phase-2 randomized study (PRISMA-2)

التفاصيل البيبلوغرافية
العنوان: Pharmacokinetics, safety, and tolerability of four 28-day cycle intramuscular injections for risperidone-ISM 75 mg in patients with schizophrenia: A phase-2 randomized study (PRISMA-2)
المؤلفون: Anta, L., Llaudó, J., Ayani, I., Gorostidi, B., Monreal, M., Martínez-González, J., Ochoa, L., Gutierro, I.
المصدر: In European Psychiatry March 2016 33 Supplement:S240-S241
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09249338
DOI:10.1016/j.eurpsy.2016.01.605